US HB3008 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 48-2)
Status: Introduced on April 28 2023 - 25% progression
Action: 2023-05-05 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 28 2023 - 25% progression
Action: 2023-05-05 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to provide for notification by manufacturers of critical essential medicines of increased demand of such drugs, and for other purposes.
Title
Drug Shortage Prevention Act of 2023
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-05-05 | House | Referred to the Subcommittee on Health. |
| 2023-04-28 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-04-28 | House | Introduced in House |
Same As/Similar To
HB4697 (Related) 2023-07-21 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/3008/all-info |
| Text | https://www.congress.gov/118/bills/hr3008/BILLS-118hr3008ih.pdf |
